KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

ACM Research (ACMR) EBT (2016 - 2025)

ACM Research (ACMR) has disclosed EBT for 10 consecutive years, with $20.8 million as the latest value for Q4 2025.

  • On a quarterly basis, EBT fell 63.18% to $20.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was $135.2 million, a 18.71% decrease, with the full-year FY2025 number at $135.2 million, down 18.71% from a year prior.
  • EBT was $20.8 million for Q4 2025 at ACM Research, down from $49.1 million in the prior quarter.
  • In the past five years, EBT ranged from a high of $56.4 million in Q4 2024 to a low of -$11.5 million in Q1 2022.
  • A 5-year average of $26.4 million and a median of $26.8 million in 2024 define the central range for EBT.
  • Biggest YoY gain for EBT was 244.97% in 2022; the steepest drop was 475.29% in 2022.
  • ACM Research's EBT stood at $21.8 million in 2021, then fell by 22.63% to $16.8 million in 2022, then surged by 86.59% to $31.4 million in 2023, then surged by 79.54% to $56.4 million in 2024, then tumbled by 63.18% to $20.8 million in 2025.
  • Per Business Quant, the three most recent readings for ACMR's EBT are $20.8 million (Q4 2025), $49.1 million (Q3 2025), and $38.2 million (Q2 2025).